Coca-Cola

Coca-Cola delivered Q1 2026 organic revenue growth of 10% and unit case growth of 3% — both above consensus expectations heading into the print. Management raised full-year 2026 guidance to 4-5% organic revenue growth and 6-7% currency-neutral EPS growth, signaling that the operating momentum extends through the rest of the year. The leadership transition is the structural story: James Quincey served as CEO through the earnings call but officially handed over to Henrique Braun on March 31, 2026 — Braun's first full quarter as CEO will be Q2 2026, making the Q3 print (typically July) his first opportunity to set strategic framing.

What makes Coca-Cola distinctive in 2026 is the geographic mix divergence. In Latin America, volume growth in Brazil and Central America successfully offset declines in Mexico (impacted by the implementation of the new sugar tax) and Argentina (broader consumer-spending weakness). The North America business continues to deliver mid-single-digit volume growth driven by Coke Zero Sugar, Topo Chico, and Fairlife — Fairlife alone is now annualizing above $5 billion in revenue, becoming Coca-Cola's fastest-growing acquired brand. The international business added another 80 basis points of price/mix in Q1 versus Q4 2025, signaling that Coca-Cola's pricing power remains intact even after the post-2022 inflation cycle has normalized in most consumer-staples categories.

Coca-Cola is Warren Buffett's most iconic equity holding — Berkshire Hathaway has held 400 million shares continuously since 1994 (cost basis approximately $1.3 billion, current value roughly $26 billion at $66 per share). The position is the third-largest in Berkshire's portfolio after Apple and American Express, and Buffett has not trimmed a single share through any of the multi-year dividend hikes. The position generates roughly $800 million in annual dividend income for Berkshire and represents the textbook 'compounder' that Buffett uses in shareholder-letter case studies.

Beyond Berkshire, Coca-Cola is held by Terry Smith of Fundsmith continuously since fund inception, by Bill Gates' Cascade Investment, and by various dividend-focused mutual funds at material scale. Bill Ackman does not hold KO; Stanley Druckenmiller does not currently hold but cycled in/out 2024. Insider activity has been routine — James Quincey's 10b5-1 sales paused starting Q4 2025 in advance of the leadership transition; Henrique Braun's first 10b5-1 plan is expected to be filed in Q3 2026. CFO John Murphy has not transacted since 2023. The most-watched insider event remains Buffett's Q4 13F filing each February — any reduction (which has not occurred since the 1994 initiation) would constitute the single largest signal in consumer staples.

Coca-Cola trades at $66 per share, roughly 23× consensus FY2026 EPS of $2.92 — a slight premium to PepsiCo at 20× and a modest discount to Hershey at 25×. Dividend yield of 2.9% with 63 consecutive years of dividend increases (Dividend King status) anchors the position for income-focused investors. EV/EBITDA sits at approximately 19× versus PepsiCo at 16× and Procter & Gamble at 18×. Wall Street consensus across 26 covering firms averages $76 (Morgan Stanley $80, Goldman $78, JPMorgan $74, Bernstein $68 as the bear), implying ~15% upside. The valuation premium versus PepsiCo is justified by stronger international diversification, Fairlife growth contribution, and Berkshire's anchor position.

1. July 22, 2026 (estimated): Q2 2026 earnings — Henrique Braun's first full quarter as CEO; first opportunity for the new framework, capital allocation philosophy, and any strategic emphasis change relative to Quincey's tenure
2. October 2026 (estimated): Q3 2026 earnings — first full quarter to assess whether Mexico sugar tax impact stabilizes or extends; first read on whether Brazil/Central America offset is structural or one-quarter weakness
3. February 2027: Berkshire Q4 2026 13F filing — the most-watched smart-money disclosure in consumer staples; any KO trim would constitute the largest single negative signal in this sector since 1994

Coca-Cola is the cleanest defensive compounder I track and arguably the highest-quality consumer-staples holding for a multi-decade portfolio. You get Buffett-validated 32-year continuous holding, 63 consecutive years of dividend increases, and Fairlife at $5B annualized run-rate providing the growth optionality that legacy CSDs lack. My add-trigger is any quarter where Fairlife growth is disclosed at 25%+ AND Latin America volume growth turns positive (signaling Mexico sugar-tax impact has stabilized) — that combination would invalidate the consumer-staples bear case. I would not chase KO above $72; I am building the position aggressively at any pullback below $62 where the dividend yield exceeds 3.1% and the multiple compresses below 22×. The thesis breaks if GLP-1 penetration accelerates beyond consensus and management does not articulate a credible Fairlife-driven offset.